These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2332628

  • 21. Deficient tumor-specific immunity in old mice: in vivo mediation by suppressor cells, and correction of the defect by interleukin 2 supplementation in vitro but not in vivo.
    Bruley-Rosset M, Payelle B.
    Eur J Immunol; 1987 Mar; 17(3):307-12. PubMed ID: 2952510
    [Abstract] [Full Text] [Related]

  • 22. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 23. Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivo.
    Cheever MA, Klarnet JP, Peace DJ, Greenberg PD.
    Prog Clin Biol Res; 1987 May 25; 244():49-58. PubMed ID: 3498958
    [Abstract] [Full Text] [Related]

  • 24. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R, Kamdar SJ, Duffy TM, Krupke DM, Fuller JA, Dudley ME.
    Anticancer Res; 1995 May 25; 15(2):441-7. PubMed ID: 7763019
    [Abstract] [Full Text] [Related]

  • 25. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA, Flye MW.
    J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414
    [Abstract] [Full Text] [Related]

  • 26. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 27. T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivo.
    Crossland KD, Lee VK, Chen W, Riddell SR, Greenberg PD, Cheever MA.
    J Immunol; 1991 Jun 15; 146(12):4414-20. PubMed ID: 1674958
    [Abstract] [Full Text] [Related]

  • 28. Potential for specific cancer therapy with immune T lymphocytes.
    Cheever MA, Greenberg PD, Fefer A.
    J Biol Response Mod; 1984 Jun 15; 3(2):113-27. PubMed ID: 6233396
    [Abstract] [Full Text] [Related]

  • 29. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
    Chou T, Chang AE, Shu SY.
    J Immunol; 1988 Apr 01; 140(7):2453-61. PubMed ID: 2450925
    [Abstract] [Full Text] [Related]

  • 30. Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis.
    Loeffler CM, Platt JL, Anderson PM, Katsanis E, Ochoa JB, Urba WJ, Longo DL, Leonard AS, Ochoa AC.
    Cancer Res; 1991 Apr 15; 51(8):2127-32. PubMed ID: 1826232
    [Abstract] [Full Text] [Related]

  • 31. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep 15; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 32. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
    Shu S, Rosenberg SA.
    J Immunol; 1985 Oct 15; 135(4):2895-903. PubMed ID: 2411817
    [Abstract] [Full Text] [Related]

  • 33. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.
    Cheever MA, Thompson DB, Klarnet JP, Greenberg PD.
    J Exp Med; 1986 May 01; 163(5):1100-12. PubMed ID: 3084700
    [Abstract] [Full Text] [Related]

  • 34. Requirements for T cell recognition and elimination of retrovirally-transformed cells.
    Greenberg P, Klarnet J, Kern D, Okuno K, Riddell S, Cheever M.
    Princess Takamatsu Symp; 1988 May 01; 19():287-301. PubMed ID: 2479634
    [Abstract] [Full Text] [Related]

  • 35. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.
    Greenberg PD.
    J Immunol; 1986 Mar 01; 136(5):1917-22. PubMed ID: 3485134
    [Abstract] [Full Text] [Related]

  • 36. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
    Klarnet JP, Kern DE, Dower SK, Matis LA, Cheever MA, Greenberg PD.
    J Immunol; 1989 Apr 01; 142(7):2187-91. PubMed ID: 2466890
    [Abstract] [Full Text] [Related]

  • 37. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 38. Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells.
    Schultz KR, Klarnet JP, Peace DJ, Cheever MA, Badger CC, Bernstein ID, Greenberg PD.
    Cancer Res; 1990 Sep 01; 50(17):5421-5. PubMed ID: 2386946
    [Abstract] [Full Text] [Related]

  • 39. Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing mice.
    Nomi S, Naito K, Kahan BD, Pellis NR.
    Cancer Res; 1986 Nov 01; 46(11):5606-10. PubMed ID: 2875791
    [Abstract] [Full Text] [Related]

  • 40. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD, Lahaye T, Sorenson GD, Glasebrook AL, Horvath C, Brunner KT.
    J Immunol; 1984 Sep 01; 133(3):1664-70. PubMed ID: 6205090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.